Novartis' Kymriah to Be First CAR-T Therapy Available Through NHS England

10:37 EDT 5 Sep 2018 | Pharmaceutical Processing

News
NHS England will provide certain children and young adults with Kymriah (tisagenlecleucel), Novartis’ CAR-T cell therapy.
Staff Author: 
Catherine Sbeglia
Topics: 
Regulatory

More From BioPortfolio on "Novartis' Kymriah to Be First CAR-T Therapy Available Through NHS England"